Brief: Altamira Therapeutics Completes Interim Sample Size Analysis Of Covamid Trial With Bentrio

Altamira Therapeutics

01/08/2022 14:52

Aug 1 (Reuters) - Altamira Therapeutics Ltd  CYTO.O :
    * ALTAMIRA THERAPEUTICS COMPLETES INTERIM SAMPLE SIZE ANALYSIS OF COVAMID
TRIAL
WITH BENTRIO IN ACUTE COVID-19
    * ALTAMIRA THERAPEUTICS LTD - ENROLLMENT TO BE CONTINUED TO 160 SUBJECTS,
ADDING
24 TO ENSURE ADEQUATE STATISTICAL POWER
    * ALTAMIRA THERAPEUTICS LTD - TOP-LINE DATA READ-OUT FROM TRIAL EXPECTED IN
EARLY
Q4-22

Source text for Eikon:  ID:nGNX5PT0MS 
Further company coverage:  CYTO.O 

 ((Reuters.Briefs@thomsonreuters.com;))